News

Goldline Pharmaceutical Limited informed the Bombay Stock Exchange that the trading window for its securities will be closed from October 1, 2026, for designated persons and their immediate relatives, pending consideration of the company’s unaudited financial results for the half year ended September 30, 2026, with the board meeting date to be announced separately.

Goldline Pharmaceutical announced that the Annual General Meeting(AGM) of the company will be held on 29 August 2026.

Goldline Pharmaceutical will hold a meeting of the Board of Directors of the Company on 9 June 2026.